FGF2 and facial paralysis: Growth factors such as basic fibroblast growth factor (bFGF) can reduce the mortality rate of facial nerve cells and improve facial movement function; gonadal steroids can rescue motor neurons through specific mechanisms; immunomodulators such as passively transferred anti-HSV-1 antibodies or immune T cells can prevent facial paralysis, but early intervention is required.